We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
GMED

Price
57.87
Stock movement down
-0.23 (-0.38%)
Company name
Globus Medical
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Markedsværdi
6.81B
Ent værdi
7.21B
Pris/omsætning
2.75
Pris/bog
1.67
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
-
Efterfølgende P/E
74.46
Fremtidig P/E
16.76
PEG
-
EPS-vekst
-7.04%
1 års afkast
-13.58%
3 års afkast
-3.37%
5 års afkast
1.98%
10 års afkast
8.67%
Senest opdateret: 2025-09-12

UDBYTTE

GMED betaler ikke udbytte

iO Charts is a Seeking Alpha partner

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E74.46
Pris til OCF16.42
Pris til FCF23.19
Pris til EBITDA16.23
EV i forhold til EBITDA17.17

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning2.75
Pris til egenkapital1.67
EV i forhold til salg2.91

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier112.63M
EPS (TTM)0.66
FCF pr. aktie (TTM)2.13

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)2.48B
Bruttofortjeneste (TTM)1.35B
Driftsindkomst (TTM)164.47M
Nettoindkomst (TTM)91.51M
EPS (TTM)0.66
EPS (1 år frem)3.61

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)54.53%
Driftsmargin (TTM)6.64%
Fortjenstmargin (TTM)3.69%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter622.77M
Nettotilgodehavender588.05M
Omsætningsaktiver i alt2.06B
Goodwill1.43B
Immaterielle aktiver842.78M
Ejendomme, anlæg og udstyr1.13B
Sum aktiver5.09B
Kreditor57.54M
Kortfristet/nuværende langsigtet gæld534.56M
Summen af kortfristede forpligtelser818.07M
Sum gæld1.02B
Aktionærernes egenkapital4.07B
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)414.97M
Investeringsudgifter (TTM)121.20M
Fri pengestrøm (TTM)293.77M
Udbetalt udbytte (TTM)0.00

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast2.25%
Afkast af aktiver1.80%
Afkast af investeret kapital2.03%
Kontant afkast af investeret kapital6.50%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning60.52
Daglig høj61.04
Daglig lav59.87
Daglig volumen606K
Højeste gennem alle tider93.32
1 års analytiker estimat82.55
Beta1.20
EPS (TTM)0.66
Udbytte pr. aktie-
Ex-div dato-
Næste dato for resultatpræsentation11 Nov 2025

Nedsidepotensial

Loading...
Nedsidepotensial-data
GMEDS&P500
Nuværende prisfald fra top notering-35.17%-1.46%
Højeste prisfald-47.91%-56.47%
Højeste efterår dato13 Nov 20239 Mar 2009
Gennemsnitlig fald fra toppen-15.32%-10.99%
Gennemsnitlig tid til nyt højdepunkt20 days12 days
Maks. tid til nyt højdepunkt807 days1805 days
OPLYSNINGER OM VIRKSOMHEDEN
GMED (Globus Medical) company logo
Markedsværdi
6.81B
Markedsværdi kategori
Mid-cap
Beskrivelse
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Personale
5300
Investor relationer
-
SEC-indsendelser
Adm. direktør
David M. Demski
Land
USA
By
Audubon
Aktietype
Common stock
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...